RecruitingNCT04310241

Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy

Oculomotor Disorders: Experimental and Clinical Study


Sponsor

The Cleveland Clinic

Enrollment

150 participants

Start Date

Feb 21, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.


Eligibility

Min Age: 6 MonthsMax Age: 90 Years

Inclusion Criteria1

  • History of amblyopia or presence of amblyogenic risk factors.

Exclusion Criteria1

  • History of neurologic disorders

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPatching therapy, Glasses

Patching, glasses and strabismus surgery are commonly employed measures in treatment of amblyopia and strabismus.


Locations(1)

Cleveland Clinic

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04310241


Related Trials